| Page 24 | Cafepharma

You are here

Primary tabs

Indivior to Sell Rights in China for $122 Million

Post date: February 6, 2019 - 9:30am

Another Immuno-Oncology Company, Another $90+ Million IPO

Post date: February 4, 2019 - 9:16pm

Microbiome Report for Week Ending 2/2/19

Post date: February 4, 2019 - 3:53pm

Ophthalmic Medtech Company Avedro Launches $92 Million IPO

Post date: February 4, 2019 - 10:14am

Immuno-Oncology Company Plans $92 Million IPO

Post date: February 2, 2019 - 3:05pm

Eli Lilly Loxo Oncology Transaction Clears A Hurdle

Post date: February 1, 2019 - 9:43am

MorphoSys Settles Patent Lawsuit with Janssen and Genmab

Post date: February 1, 2019 - 9:25am

Sunovion Receives Complete Response Letter from FDA for Parkinson’s Disease Drug

Post date: January 31, 2019 - 10:19am

BioXyTran Files for $10 Million Offering to Advance Stroke and Wound Healing Candidates

Post date: January 31, 2019 - 10:05am

Azitra Completes Enrollment in Clinical Trial of Topical Commensal Microbiological Agent

Post date: January 30, 2019 - 10:18am

Pages